An interview with David Sackett,2014–2015

Ivy AC . Krebiozen. Science 1951; 114: 285–286.

Sackett DL . A 1955 clinical trial report that changed my career. JLL Bulletin: Commentaries on the history of treatment evaluation, 2008, http://www.jameslindlibrary.org/articles/a-1955-clinical-trial-report-that-changed-my-career/ (accessed 25 June 2015).

Chalmers TC Eckhardt RD Reynolds WE . The treatment of acute infectious hepatitis. Controlled studies of the effects of diet, rest, and physical reconditioning on the acute course of the disease and on the incidence of relapses and residual abnormalities. J Clin Invest 1955; 34: 1163–1235.

Bunker JP Barnes BA Mosteller F . Costs, risks, and benefits of surgery. New York: Oxford University Press, 1967.

Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic pressures averaging 115 through 129 mm Hg. JAMA 1967; 202: 1028–1034.

Levine MI Sackett MF . Results of BCG immunization in New York City. Am Rev Tuberc 1946; 53: 517–532.

Sackett DL . The tactics of performing therapeutic trials. In: Haynes RB Sackett DL Guyatt GH . (eds) Clinical epidemiology: how to do clinical practice research. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2006, p. 86.

The Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980; 303: 1038–1041.

Walsh M Srinathan SK McAuley DF . The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. J Clin Epidemiol 2014; 67: 622–628.

Cobb LA Thomas GI Dillard DH . An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med 1959; 260: 1115–1118.

Ratcliff JD . New surgery for ailing hearts. Readers’ Digest, July 1957, pp. 109–112.

Martini P . Methodenlehre der Therapeutischen Untersuchung [Methodological principles for therapeutic investigations]. Berlin: Springer, 1932.

Noseworthy JH Ebers GC Vandervoort MK . The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 1994; 44: 16–20; reprinted as a classical article in Neurology 2001; 57(12 Suppl. 5): S31–S35.

Sackett DL . Clinician-trialist rounds: 6. Testing for blindness at the end of your trial is a mug’s game. Clin Trials 2011; 8: 674–676.

The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53–59.

Redmond CK Colton T (eds). Biostatistics in clinical trials. Hoboken, NJ: Wiley, 2001, p. 241.

North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–453.

Ellenberg SS Fleming TR DeMets DL . Data monitoring in clinical trials: a practical perspective. Hoboken, NJ: John Wiley & Sons, 2003.

Clemens F Elbourne D Darbyshire J . Data monitoring in randomized controlled trials: surveys of recent practice and policies. Clin Trials 2005; 2: 22–33.

Standing Committee on Postgraduate Medical and Dental Education (SCOPME). Supporting doctors and dentists at work: an enquiry into mentoring. SCOPME report. London: Department of Health, 1998.

Straus SE Sackett DL . Mentorship in academic medicine. Oxford: Wiley Blackwell; BMJ Books, 2014.

Straus SE Sackett DL . Clinician-trialist rounds: 7. Mentoring: why every clinician-trialist needs to get mentored. Clin Trials 2011; 8: 765–767.

Straus SE Sackett DL . Clinician-trialist rounds: 8. Mentoring—part 2: the structure and function of effective mentoring linkage, resources, and academic opportunities. Clin Trials 2012; 9: 128–131.

Straus SE Sackett DL . Clinician-trialist rounds: 9. Mentoring—part 3: the structure and function of effective mentoring: advice and protection. Clin Trials 2012; 9: 272–274.

Straus SE Sackett DL . Clinician-trialist rounds: 10. Mentoring—part 4: attributes of an effective mentor. Clin Trials 2012; 9: 367–369.

Sackett DL Clinician-trialist rounds: 21. The presenting complaints, diagnoses and treatments of mentorships in trouble—part 1: dysfunctional mentorship meetings. Clin Trials 2014; 11: 376–379.

Straus SE Sackett DL . Clinician-trialist rounds: 22. The presenting complaints, diagnoses, and treatments of mentorships in trouble—part 2: abuses of power. Clin Trials 2014; 11: 508–511.

Sackett DL . Clinician-trialist rounds: 3. Priority setting for academic success. Clin Trials 2011; 8: 235–237.

Sackett DL . Clinician-trialist rounds: 1. Inauguration, and an introduction to time-management for survival. Clin Trials 2010; 7: 749–751.

Sackett DL . Clinician-trialist rounds: 2. Time-management of your clinical practice and teaching. Clin Trials 2011; 8: 112–114.

Goodman SN . On making clinical trials possible. Clin Trials 2010; 7: 621.